HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Marco Carli Selected Research

Chlorpromazine (Thorazine)

11/2020Allosteric Modulators of G Protein-Coupled Dopamine and Serotonin Receptors: A New Class of Atypical Antipsychotics.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Marco Carli Research Topics

Disease

5Bipolar Disorder (Manic Depressive Psychosis)
06/2023 - 01/2017
5Schizophrenia (Dementia Praecox)
10/2022 - 01/2017
4Neoplasms (Cancer)
11/2023 - 01/2020
4Parkinson Disease (Parkinson's Disease)
10/2022 - 12/2018
3Substance-Related Disorders (Drug Abuse)
10/2023 - 01/2020
3Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder)
06/2023 - 01/2021
2Cancer Pain
10/2023 - 01/2020
2Psychotic Disorders (Schizoaffective Disorder)
03/2021 - 12/2018
1Melanoma (Melanoma, Malignant)
11/2023
1Weight Loss (Weight Reduction)
11/2023
1Opioid-Related Disorders (Opiate Addiction)
10/2023
1Glioblastoma (Glioblastoma Multiforme)
01/2023
1Brain Neoplasms (Brain Tumor)
01/2023
1Liver Neoplasms (Liver Cancer)
01/2023
1Catalepsy
10/2022
1Metabolic Syndrome (Dysmetabolic Syndrome X)
03/2021
1Borderline Personality Disorder (Personality Disorders, Borderline)
01/2021
1Mental Disorders (Mental Disorder)
11/2020
1Pathologic Processes
01/2020
1Pain (Aches)
01/2020
1Weight Gain
12/2018
1Agranulocytosis (Granulocytopenia)
12/2018
1Treatment-Resistant Schizophrenia
12/2018
1Glioma (Gliomas)
01/2017

Drug/Important Bio-Agent (IBA)

3Valproic Acid (Depakote)FDA LinkGeneric
01/2023 - 01/2022
3Antipsychotic Agents (Antipsychotics)IBA
01/2023 - 11/2020
3LithiumIBA
01/2023 - 01/2022
3Clozapine (Clozaril)FDA LinkGeneric
11/2020 - 01/2017
2Opioid Analgesics (Opioids)IBA
10/2023 - 01/2020
1Type 4 Melanocortin Receptor (Melanocortin-4 Receptor)IBA
11/2023
1VemurafenibIBA
11/2023
12- (2- (2- (5- bromo- 2- methoxyphenyl)ethyl)- 3- fluorophenyl)- 4,5- dihydro- 1H- imidazoleIBA
11/2023
1Methadone (Dolophine)FDA LinkGeneric
10/2023
1Amphetamine (Amfetamine)FDA LinkGeneric
06/2023
1Lithium Carbonate (Eskalith)FDA LinkGeneric
01/2023
1Antineoplastic Agents (Antineoplastics)IBA
01/2023
1Lithium ChlorideIBA
01/2023
1atipamezoleIBA
10/2022
1RacloprideIBA
10/2022
1RS 79948-197IBA
10/2022
1naxagolideIBA
06/2022
1RotenoneIBA
08/2021
1NeurotoxinsIBA
08/2021
1Oxidopamine (6 Hydroxydopamine)IBA
08/2021
11-Methyl-4-phenylpyridinium (1 Methyl 4 phenylpyridinium)IBA
08/2021
1Cocaine (Cocaine HCl)IBA
04/2021
1Antidepressive Agents (Antidepressants)IBA
01/2021
1Dopamine Receptors (Dopamine Receptor)IBA
11/2020
1Chlorpromazine (Thorazine)FDA Link
11/2020
1CannabinoidsIBA
01/2020
1Morphine (MS Contin)FDA LinkGeneric
01/2020
1Opioid Receptors (Opioid Receptor)IBA
01/2020
1Dronabinol (THC)FDA LinkGeneric
01/2020
1Dopamine (Intropin)FDA LinkGeneric
01/2018
1Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA
01/2017
1Phosphotransferases (Kinase)IBA
01/2017
1Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA
01/2017
15-HT2A Serotonin Receptor (5 HT2A Receptor)IBA
01/2017

Therapy/Procedure

2Drug Therapy (Chemotherapy)
06/2023 - 01/2023
1Therapeutics
11/2023